Clinical Development Fellowship
This two-year Hematology-Oncology Clinical Development fellowship in partnership with the University of the Pacific provides extensive exposure to clinical development activities and fosters an understanding of clinical research principles. The fellow will function as a Clinical Scientist and will support Medical Directors/senior-level Clinical Scientists on a diverse set of clinical development activities.
The fellowship program begins in July 2027.
BeOne has built an extensive array of novel in vitro, ex vivo and in vivo cancer models to help better select targets, and to screen and evaluate agents that may have significant potential, either alone or in combination.
By integrating elements of the human immune system, our cancer models enable us to evaluate potential drug candidates in conditions that mimic cancer at the time of treatment. This is especially significant when drug discovery depends on evaluating multiple combinations and regimens that target specific mutations while simultaneously immobilizing cancer cells’ defenses. In the role of a Clinical Scientist, the fellow will gain a strong foundation in clinical oncology research.
Program Structure
The fellow will function as a clinical scientist and will support medical directors/senior level clinical scientists on the following activities:
- Serve as a clinical science representative on cross-functional sub-teams (i.e., protocol execution, clinical, biomarkers, pharmacokinetics)
- Create, review and present clinical slides for internal (i.e., BeOne) and external meetings (e.g. Investigator meetings, scientific congresses, advisory boards, site visits, site staff training)
- Develop understanding of Good Clinical Practice (GCP), International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), FDA, EMA, NICE and other relevant guidelines and regulations
- Draft abstracts, posters, manuscripts for scientific meetings
- Author and review of clinical documents (i.e., clinical trial protocols, clarifications and amendments, informed consents, investigator brochures, clinical study reports, investigational new drug submissions)
- Respond to inquiries from health authorities (e.g., FDA, EMA) and study site ethics committees
- Partner with the data management team to assist with the development of case report forms
- Serve as a primary point of contact for study inquiries
- Contribute to ongoing review of the integrity of clinical trial data
- Develop understanding of the entire clinical development process from Phase I-IV
Clinical Development (Hematology) Leadership and Fellowship Steering Committee
Clinical Development (Hematology) Leadership
Amit Agarwal, M.D., Ph.D.
Chief Medical Officer,
Hematology
Remus Vezan, MD, Ph.D.
Vice President,
Clinical Development, Hematology
Toay Foster-Ortiz, M.A.O.M.
Executive Director,
Chief of Staff to Hematology Chief Medical Officer (CMO)
Fellowship Program Steering Committee
Sheel Patel, PharmD
Director, Clinical Science
Charity Henrich, PharmD
Senior Manager, Clinical Science
Wai Chan, Ph.D.
Senior Director, Clinical Science
Current Fellows
Wadie Sawaged, PharmD
2025-2027 Clinical Development Fellow
Zachary Ison, PharmD
2025-2027 Clinical Development Fellow
Eligibility / Qualification Criteria
Candidates must have earned a PharmD from an ACPE accredited college of pharmacy before the start of the fellowship term. Candidates must be legally authorized to work in the United States at the time of hire and must maintain valid work authorization for the duration of the fellowship. University of the Pacific does not provide immigration sponsorship (e.g., H-1B petitions or green card sponsorship) for fellowship positions. All candidates must satisfy applicable employment eligibility verification (Form I-9) requirements.
How to Apply
Candidates must submit via email (pharmfip@pacific.edu) all the following application materials by the deadline listed on the University’s website:
- Letter of intent
- Updated curriculum vitae (CV)
- Three (3) letters of recommendation emailed directly from the letter writer
-
Please address letters of recommendation and letters of intent to:
Sachin A. Shah, PharmD, FACC, FAHA
Director, Fellowship in Industry Program
Professor of Pharmacy Practice
-
Please address letters of recommendation and letters of intent to:
- One professional writing sample that demonstrates medical writing ability
- Unofficial pharmacy school transcript emailed to FIP director
Timelines
- For application timelines, please refer to the University of the Pacific Fellowship in Industry Program Website.
Contact Information
For any questions, please contact pharmfip@pacific.edu